Home › Funds › First Turn Management, LLC › CYTK
First Turn Management, LLC position in CYTK
CYTOKINETICS INC · Health Care
First Turn Management, LLC reported holding 357,945 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$23.6M, representing 3.13% of its reported portfolio and ranking #11 among its reported holdings. First Turn Management, LLC has disclosed CYTK holdings in 9 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How First Turn Management, LLC's CYTK position evolved
First Turn Management, LLC first disclosed a stake in CYTK in Q4 2023 at 807,444 shares (US$67.4M). Across 9 filings, First Turn Management, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 357,945 shares valued at US$23.6M — a reduction of -169,467 shares quarter over quarter.. Notable position changes include a 47% trim in Q1 2024 (shares fell 23% over the following quarter), a 86% increase in Q2 2026 (shares fell 23% over the following quarter), a 32% trim in Q3 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 807.44K | $67.41M | New |
| Q1 2024 | 430.35K | $30.17M | Reduce |
| Q2 2024 | 293.32K | $15.89M | Reduce |
| Q3 2024 | 223.15K | $11.78M | Reduce |
| Q3 2025 | 254.79K | $14.00M | New |
| Q4 2025 | 325.67K | $20.69M | Add |
| Q1 2026 | 283.70K | $18.70M | Reduce |
| Q2 2026 | 527.41K | $44.93M | Add |
| Q3 2026 | 357.94K | $23.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 40 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 4.90M sh · $322.96M · Q3 2026
- Polar Capital Holdings Plc 9.64M sh · $227.69M · Q3 2026
- RTW INVESTMENTS, LP 2.86M sh · $188.63M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.18M sh · $77.79M · Q3 2026
- Integral Health Asset Management, LLC 1.60M sh · $72.50M · Q3 2026
- GW&K Investment Management, LLC 1.02M sh · $67.08M · Q3 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $64.62M · Q3 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
- Melqart Asset Management (UK) Ltd 761.54K sh · $50.19M · Q3 2026
- Affinity Asset Advisors, LLC 750.00K sh · $49.43M · Q3 2026
More on First Turn Management, LLC
FAQ
How long has First Turn Management, LLC held CYTK?
First Turn Management, LLC has disclosed CYTK holdings in 9 of the last 12 reported quarters, going back to Q4 2023.
What is First Turn Management, LLC's current position in CYTK?
As of Q3 2026, First Turn Management, LLC holds 357.94K shares of CYTK (CYTOKINETICS INC), valued at $23.59M, representing 3.13% of its reported portfolio and ranking #11.
Has First Turn Management, LLC been buying or selling CYTK?
In the latest 13F filing (Q3 2026), First Turn Management, LLC reduced its position in CYTK.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.